Impaired subendocardial perfusion in patients with metabolic syndrome.
Francesco FantinAnna GianiLudovico GaspariniAndrea P RossiElena ZoicoGloria MazzaliMauro ZamboniPublished in: Diabetes & vascular disease research (2022)
The reduced SEVR in metabolic syndrome patients could be an important pathophysiological determinant of the increased cardiovascular risk.